Cargando…
Using Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer Therapy
With multiple omics strategies being applied to several cancer genomics projects, researchers have the opportunity to develop a rational planning of targeted cancer therapy. The investigation of such numerous and diverse pharmacogenomic datasets is a complex task. It requires biological knowledge an...
Autores principales: | Belizário, José E., Sangiuliano, Beatriz A., Perez-Sosa, Marcela, Neyra, Jennifer M., Moreira, Dayson F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040751/ https://www.ncbi.nlm.nih.gov/pubmed/27746730 http://dx.doi.org/10.3389/fphar.2016.00312 |
Ejemplares similares
-
Cell Death-Associated Molecular-Pattern Molecules: Inflammatory Signaling and Control
por: Sangiuliano, Beatriz, et al.
Publicado: (2014) -
Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics
por: Pandi, Maria-Theodora, et al.
Publicado: (2020) -
Pharmacogenomics of Prostaglandin and Leukotriene Receptors
por: Cornejo-García, José A., et al.
Publicado: (2016) -
A Systematic Strategy for Discovering a Therapeutic Drug for Alzheimer’s Disease and Its Target Molecule
por: Yang, Zhiyou, et al.
Publicado: (2017) -
Pharmacogenomics: What is Next?
por: di Iulio, Julia, et al.
Publicado: (2012)